It could help over 80 million Americans living with severe acute pain and reduce the effects of the opioid crisis.A new type of painkiller aimed at treating pain from an injury or surgery has been ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...

President Donald Trump has nominated Kennedy to be the secretary of the U.S. Department of Health and Human Services, which ...

Robert F. Kennedy Jr. 's bid to be the nation's top health official is uncertain after a key Republican joined Democrats to ...

The recalled Braga Fresh Marketside Broccoli was washed, ready-to-eat, and sold in 12-ounce bags at Walmart stores in 20 states including Alaska, Arkansas, Arizona, California, Colorado, Idaho, ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Lively said patients’ primary concerns about prescriptions are cost and convenience/access. The CareArc pharmacy will enable ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...

Plus, NBC News spoke to trans service members about their thoughts on President Trump's executive order banning trans people from enlisting and serving in the military.

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.